APA (7th ed.) Citation
(2026). Correction: MiR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5. PLOS ONE.
Chicago Style (17th ed.) Citation
"Correction: MiR-217 Inhibits Triple-negative Breast Cancer Cell Growth, Migration, and Invasion Through Targeting KLF5." PLOS ONE 2026.
MLA (9th ed.) Citation
"Correction: MiR-217 Inhibits Triple-negative Breast Cancer Cell Growth, Migration, and Invasion Through Targeting KLF5." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.